For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.
The Indianapolis drugmaker's animal-health division is bulking up its companion-animal business by buying Boehringer Ingelheim International's U.S. feline, canine and rabies medications.
Rainer Fischer most recently served as senior executive director of the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany. The institute is part of the largest applied science research organization in Europe.
A new poll shows that a growing number of people feel drug prices are unreasonable, and they favor a variety of government actions to keep prices down.
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.
To succeed in the 21st century, we need easy access—and we need to be easily accessible to—markets, ideas, capital and talent from coast to coast and around the world. Those are the four elements of the new connectivity economy.
WISH-TV political reporter Jim Shella has spent 40 years in the news business—most of it at the Indiana Statehouse—and 25 years as host of “Indiana Week in Review” on WFYI.
On Jan. 1, Dave Ricks becomes CEO of drugmaker Eli Lilly and Co. as it tries to launch new products after a tough stretch of patent expirations. To prepare, Ricks has spent a lot of time with outgoing CEO John Lechleiter “learning from the master.”
The former project manager for F.A. Wilhelm Construction Co. faces 20 years in prison for allegedly creating a fake business and billing his employer for materials, as well as making a false tax return.
At the new event, more than 7,000 Marion County eighth-graders will get hands-on experience in eight job sectors, aided by some 3,000 volunteers from more than 100 companies.
Drugmakers facing a price war in the diabetes market, including Indianapolis-based Eli Lilly and Co., are betting on new technologies to withstand the competition.
The head of Pfizer Inc., America’s biggest drugmaker, said Democratic presidential nominee Hillary Clinton’s proposals to contain the price of pharmaceuticals would be “very negative” for the industry and are a step toward single-payer health care.
Eli Lilly and Co. and its partner cannot stop competitors from selling generic versions of testosterone treatment Axiron, a federal judge in Indianapolis has ruled.
Named AZD3293, the drug belongs to a novel class of drugs that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Advocates want to see Indiana children from families earning up to at least 200 percent of the federal poverty line have access to high-quality pre-kindergarten programs.
